MDEV vs. BBC
MDEV (First Trust Indxx Medical Devices ETF) and BBC (Virtus LifeSci Biotech Clinical Trials ETF) are both Health & Biotech Equities funds - MDEV tracks the Indxx Global Medical Equipment Index while BBC tracks the LifeSci Biotechnology Clinical Trials Index. Both are passively managed. Over the past 3 years, MDEV returned -2.86%/yr vs 19.99%/yr for BBC. A 0.53 correlation means they provide meaningful diversification when combined. MDEV charges 0.70%/yr vs 0.79%/yr for BBC.
Performance
MDEV vs. BBC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MDEV achieves a -11.48% return, which is significantly lower than BBC's 8.64% return.
MDEV
- 1D
- 0.04%
- 1M
- 1.54%
- YTD
- -11.48%
- 6M
- -12.29%
- 1Y
- -7.05%
- 3Y*
- -2.86%
- 5Y*
- —
- 10Y*
- —
BBC
- 1D
- 0.43%
- 1M
- -6.52%
- YTD
- 8.64%
- 6M
- 14.08%
- 1Y
- 116.78%
- 3Y*
- 19.99%
- 5Y*
- -1.96%
- 10Y*
- 7.64%
MDEV vs. BBC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
MDEV First Trust Indxx Medical Devices ETF | -11.48% | 2.00% | 1.79% | 7.55% | -28.59% | 4.16% |
BBC Virtus LifeSci Biotech Clinical Trials ETF | 8.64% | 63.77% | -1.11% | -1.80% | -35.13% | -22.29% |
Correlation
The correlation between MDEV and BBC is 0.38, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.38 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.46 |
Correlation (All Time) Calculated using the full available price history since Jun 24, 2021 | 0.53 |
The correlation between MDEV and BBC shifts across timeframes, from 0.38 (1 year) to 0.53 (all time), reflecting how their relationship changes across market environments.
MDEV vs. BBC - Sectors Allocation Comparison
Sectors
MDEV
BBC
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
MDEV
BBC
Basic Materials
MDEV
-
BBC
-
Communication Services
MDEV
-
BBC
-
Consumer Cyclical
MDEV
-
BBC
-
Consumer Defensive
MDEV
-
BBC
-
Energy
MDEV
-
BBC
-
Financial Services
MDEV
-
BBC
-
Industrials
MDEV
-
BBC
-
Real Estate
MDEV
-
BBC
-
Technology
MDEV
-
BBC
-
Utilities
MDEV
-
BBC
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MDEV vs. BBC — Risk / Return Rank
MDEV
BBC
MDEV vs. BBC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Indxx Medical Devices ETF (MDEV) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MDEV | BBC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.76 | ||
| Sortino ratioReturn per unit of downside risk | -4.50 | ||
| Omega ratioGain probability vs. loss probability | 0.94 | 1.46 | -0.52 |
| Calmar ratioReturn relative to maximum drawdown | -0.39 | 7.78 | -8.17 |
| Martin ratioReturn relative to average drawdown | -0.98 | 24.80 | -25.77 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| MDEV | BBC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.44 | 3.32 | -3.76 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.05 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.20 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.32 | 0.12 | -0.44 |
Drawdowns
MDEV vs. BBC - Drawdown Comparison
The maximum MDEV drawdown since its inception was -42.34%, smaller than the maximum BBC drawdown of -76.85%. Use the drawdown chart below to compare losses from any high point for MDEV and BBC.
Loading charts...
Drawdown Indicators
| MDEV | BBC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -42.34% | -76.85% | +34.51% |
Max Drawdown (1Y)Largest decline over 1 year | -18.13% | -15.10% | -3.03% |
Max Drawdown (3Y)Largest decline over 3 years | -22.50% | -54.45% | +31.95% |
Max Drawdown (5Y)Largest decline over 5 years | — | -72.44% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -76.85% | — |
Current DrawdownCurrent decline from peak | -33.76% | -30.27% | -3.49% |
Average DrawdownAverage peak-to-trough decline | -25.65% | -37.14% | +11.49% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.22% | 4.73% | +2.49% |
Volatility
MDEV vs. BBC - Volatility Comparison
The current volatility for First Trust Indxx Medical Devices ETF (MDEV) is 4.60%, while Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a volatility of 10.93%. This indicates that MDEV experiences smaller price fluctuations and is considered to be less risky than BBC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MDEV | BBC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.60% | 10.93% | -6.33% |
Volatility (6M)Calculated over the trailing 6-month period | 11.42% | 26.43% | -15.01% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.00% | 35.50% | -19.50% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.98% | 39.31% | -20.33% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.98% | 37.74% | -18.76% |
MDEV vs. BBC - Expense Ratio Comparison
MDEV has a 0.70% expense ratio, which is lower than BBC's 0.79% expense ratio.
Dividends
MDEV vs. BBC - Dividend Comparison
MDEV has not paid dividends to shareholders, while BBC's dividend yield for the trailing twelve months is around 1.56%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.56% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
MDEV First Trust Indxx Medical Devices ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
MDEV and BBC have a correlation of 0.38, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBC has higher volatility (10.93%) compared to MDEV (4.60%). In terms of maximum drawdown, MDEV dropped -42.34% vs BBC's -76.85%.
On 3-year performance, BBC leads with 19.99% vs -2.86% for MDEV. On fees, MDEV is cheaper at 0.70% per year. On volatility, MDEV has been the lower-risk option at 4.60%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, BBC has performed better with a 19.99% return vs -2.86%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
MDEV is cheaper with a 0.70% expense ratio, compared with 0.79% for BBC.
BBC has the higher dividend yield at 1.56%, compared with 0.00% for MDEV.
MDEV tracks Indxx Global Medical Equipment Index, while BBC tracks LifeSci Biotechnology Clinical Trials Index. They also come from different issuers: First Trust and Virtus Investment Partners. Their fees differ too: 0.70% for MDEV and 0.79% for BBC.
BBC currently has the higher Sharpe Ratio (3.32 vs -0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MDEV and BBC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer